Clinical Trials Logo

Mucositis Oral clinical trials

View clinical trials related to Mucositis Oral.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06031012 Not yet recruiting - Mucositis Oral Clinical Trials

Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis

Start date: September 15, 2023
Phase: Phase 3
Study type: Interventional

The goal of this study is to compare glutamine combined with thalidomide with glutamine alone in preventing radiation-induced oral mucositis. The aim of this study is to answer whether glutamine plus thalidomide could improve the median incidence time of grade 2 oral mucositis. Participants would be randomly divided into the two groups above mentioned.

NCT ID: NCT05224882 Not yet recruiting - Chemotherapy Effect Clinical Trials

Chemotherapy Oral Manifestations and Dental Awareness Among Parents

Start date: August 12, 2023
Phase:
Study type: Observational

The prevention of oral illnesses in children and adolescents undergoing oncological treatment is critical, because oral lesions caused by this therapy significantly exacerbate the clinical condition and increase the risk of infection, as well as making it harder to perform required dental procedures when needed . "The key to success in maintaining a healthy oral cavity during therapy is patient compliance. The child and the parents should be educated regarding the possible acute side effects." Pediatric cancer patients may have a lower quality of life if they have poor dental health. Preventing and treating pre-existing oral illnesses is critical to reduce problems in these people. It is critical to raise awareness of the benefits of proper oral health so that this understanding becomes a positive attitude, reducing the discomfort of these children. The American Academy of Pediatric Dentistry (AAPD) recommends pediatric oncology/hematology that Pediatric dentists must be involved in the treatment process from the moment cancer is diagnosed. This should be carried out by having a preventive and dental care plan developed based on the patient's needs before any cancer treatment is initiated. The aim of the study is primarily to report oral complications and manifestations during chemotherapy treatment in pediatric cancer patients and raise the awareness of their parents on these manifestations thus proper interventions can be carried out to prevent more serious problems.

NCT ID: NCT04303312 Not yet recruiting - Mucositis Oral Clinical Trials

Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis

Start date: December 2021
Phase: Phase 3
Study type: Interventional

Oral mucositis consequences can range from pain, decreased oral intake, impaired speech and swallowing to adverse events as severe as septicemia, increased hospitalization, and G-tube feeding A wide variety of agents have been tested to prevent OM or reduce its severity.This trial will assess the usefulness of solcoseryl and pumpkin seed oil versus Benzydamine Hydrochloride mouth wash in management of oral mucositis in patients receiving radiotherapy and/or chemotherapy.

NCT ID: NCT04080622 Not yet recruiting - Clinical trials for Stem Cell Transplant Complications

Evaluate the Efficacy of Selenium for the Prevention of Chemotherapy-induced Mucositis During Autologous Stem Cell Transplantation.

AutoSelenium
Start date: October 2019
Phase: Phase 3
Study type: Interventional

Chemotherapy-induced mucositis is an important complication after autologous stem cell transplantation. It is mainly responsible for pain and dysphagia requiring opioids and artificial nutrition. It can also induce infectious complications. A few medication has demonstrated efficacy in this setting. It has been suggested that selenium can reduce the intensity of mucositis due to its antioxydant activity. The investigators therefore perform a randomized study to confirm this preliminary data.